EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aspartame and Its Metabolites Cause Oxidative Stress and Mitochondrial and Lipid Alterations in SH-SY5Y Cells

Lea Victoria Griebsch iD, Elena Leoni Theiss, Daniel Janitschke iD, Vincent Konrad Johannes Erhardt, Tobias Erhardt, Elodie Christiane Haas, Konstantin Nicolas Kuppler, Juliane Radermacher, Oliver Walzer, Anna Andrea Lauer iD, Veronika Matschke iD, Tobias Hartmann iD und 2 weitere

Nutrients · 18.03.2023 · 15 (6) · 1467

DOI: 10.3390/nu15061467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 18.03.2023. Verfasst von Lea Victoria Griebsch und 13 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neurology, Saarland University, 66424 Homburg, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Neuroblastoma. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission under the framework programme 619 of the European Union, the EU Joint Programme-Neuro- 620 degenerative Disease Research (JPND) and BMBF grants MIND-AD, EURO-FIN- 621 GERS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to a worldwide increase in obesity and metabolic disorders such as type 2 diabetes, synthetic sweeteners such as aspartame are frequently used to substitute sugar in the diet. Possible uncertainties regarding aspartame’s ability to induce oxidative stress, amongst others, has led to the recommendation of a daily maximum dose of 40 to 50 mg per kg. To date, little is known about the effects of this non-nutritive sweetener on cellular lipid homeostasis, which, besides elevated oxidative stress, plays an important role in the pathogenesis of various diseases, including neurodegenerative diseases such as Alzheimer’s disease. In the present study, treatment of the human neuroblastoma cell line SH-SY5Y with aspartame (271.7 µM) or its three metabolites (aspartic acid, phenylalanine, and methanol (271.7 µM)), generated after digestion of aspartame in the human intestinal tract, resulted in significantly elevated oxidative stress associated with mitochondrial damage, which was illustrated with reduced cardiolipin levels, increased gene expression of SOD1/2, PINK1, and FIS1, and an increase in APF fluorescence. In addition, treatment of SH-SY5Y cells with aspartame or aspartame metabolites led to a significant increase in triacylglycerides and phospholipids, especially phosphatidylcholines and phosphatidylethanolamines, accompanied by an accumulation of lipid droplets inside neuronal cells. Due to these lipid-mediating properties, the use of aspartame as a sugar substitute should be reconsidered and the effects of aspartame on the brain metabolism should be addressed in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2NeuroblastomaHumansAspartameSweetening AgentsOxidative StressLipids

Stichwörter der Autor:innen

ROSlipid dropletslipidsmitochondrial damagephosphatidylcholinephosphatidylethanolaminesynthetic sweetener

Substanzen

AspartameSweetening AgentsLipids

Autor:innen und Institutionen

  • Experimental Neurology, Saarland University, 66424 Homburg, Germany.
  • Physical Therapy, Campus Karlsruhe, SRH University of Applied Health Sciences, 76185 Karlsruhe, Germany.
  • Nutrition Therapy and Counseling, Campus Rheinland, SRH University of Applied Health Sciences, 51377 Leverkusen, Germany.
  • Department of Cytology, Institute of Anatomy, Medical Faculty, Ruhr University Bochum, 44801 Bochum, Germany.
  • Deutsches Institut für DemenzPrävention, Saarland University, 66424 Homburg, Germany.

ORCID-Profile: Lea Victoria Griebsch, Daniel Janitschke, Anna Andrea Lauer, Veronika Matschke, Tobias Hartmann, Marcus Otto Walter Grimm

Förderung

  • European Commission under the framework programme 619 of the European Union
  • the EU Joint Programme-Neuro- 620 degenerative Disease Research (JPND) and BMBF grants MIND-AD
  • EURO-FIN- 621 GERS
  • European Commission under the framework program of the European Union
  • EU Joint Program–Neurodegenerative Disease Research (JPND) and BMBF
  • EURO-FINGERS

Zitieren

APA

Griebsch, L. V., Theiss, E. L., Janitschke, D., Erhardt, V. K. J., Erhardt, T., Haas, E. C., Kuppler, K. N., Radermacher, J., Walzer, O., Lauer, A. A., Matschke, V., Hartmann, T., Grimm, M. O. W., & Grimm, H. S. (2023). Aspartame and Its Metabolites Cause Oxidative Stress and Mitochondrial and Lipid Alterations in SH-SY5Y Cells. Nutrients, 15(6), 1467. https://doi.org/10.3390/nu15061467

Vancouver

Griebsch LV, Theiss EL, Janitschke D, Erhardt VKJ, Erhardt T, Haas EC, et al. Aspartame and Its Metabolites Cause Oxidative Stress and Mitochondrial and Lipid Alterations in SH-SY5Y Cells. Nutrients. 2023;15(6):1467. doi:10.3390/nu15061467

BibTeX
@article{Griebsch2023,
  author = {Griebsch, Lea Victoria and Theiss, Elena Leoni and Janitschke, Daniel and Erhardt, Vincent Konrad Johannes and Erhardt, Tobias and Haas, Elodie Christiane and Kuppler, Konstantin Nicolas and Radermacher, Juliane and Walzer, Oliver and Lauer, Anna Andrea and Matschke, Veronika and Hartmann, Tobias and Grimm, Marcus Otto Walter and Grimm, Heike Sabine},
  title = {Aspartame and Its Metabolites Cause Oxidative Stress and Mitochondrial and Lipid Alterations in SH-SY5Y Cells},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1467},
  doi = {10.3390/nu15061467}
}
Kostenlos starten →